Skip to main content
. 2014 Dec 29;65(630):e16–e23. doi: 10.3399/bjgp15X683113

Table 2.

Predicted risk of stroke and systemic thromboembolism by CHADS2 and CHA2DS2-VASc score at baseline and observed stroke risk over 12-month follow-up

Score CHA2DS2-VASc score CHADS2 score


n (%) Observed stroke rate n (%) n (%) Observed stroke rate n (%)
0 119 (5.3) 1 (0.8) 325 (14) 1 (0.3)
1 205 (9.1) 0 535 (24) 6 (1.1)
2 321 (14) 2 (0.6) 678 (30) 15 (2.2)
3 483 (21) 5 (1.0) 367 (16) 12 (3.3)
4 492 (22) 17 (3.5) 240 (11) 23 (9.6)
5 321 (14) 17 (5.3) 98 (4.4) 9 (9.2)
6 205 (9.1) 14 (6.8) 16 (0.7) 1 (6.3)
7 96 (4.3) 10 (10.4) NA NA
8 16 (0.7) 0 NA NA
9 1 (<0.1) 1 (100) NA NA
Low riska 170 (7.5) 1 (0.6) 325 (14) 1 (0.3)
Moderate or high riskb 2089 (92.5) 66 (3.2) 1934 (86) 66 (3.4)

NA, not applicable. CHADS2 score, C = recent congestive heart failure, H = hypertension, A = age75 years, D = diabetes mellitus, S = stroke/transient ischaemic attack (TIA); 2 points for presence of stroke/TIA and 1 point for presence of each other risk factor.4 CHA2DS2-VASc score, C = congestive heart failure, H = hypertension, A = age75 years, D = diabetes mellitus, S = stroke/TIA, V = vascular disease (peripheral arterial, myocardial infarction, or aortic plaque), A = age 65–74 years, and Sc = sex category (female); 2 points each for age75 or previous stroke/TIA and 1 point for presence of each other risk factor.13

a

Low risk by CHA2DS2-VASc score = 0 for males and 1 for females.

b

Moderate or high risk denotes a CHADS2 score1 or a CHA2DS2-VASc score1 (males) and2 (females).